Interestingly, the serum levels of MDH2 are also associated with the risk of wheelchair dependency and pulmonary function, implying that MDH2 can potentially be used as a prognostic biomarker in DMD.49 Here, MDH2 is linked to Duchenne muscular dystrophy.